Do Prophylactic Antibiotics Decrease the Rate of Urinary Tract Infections After Robot-Assisted Radical Cystectomy? A Randomized Controlled Trial.

Abstract

The purpose of this article was to investigate the role of prophylactic antibiotics after robot-assisted radical cystectomy (RARC) in the prevention of 90-day UTIs. Patients who underwent RARC with urinary diversion were randomized to standard of care (SOC) vs receiving prophylactic antibiotics (nitrofurantoin 100 mg daily or trimethoprim/sulfamethoxazole 160/800 mg daily) for 30 days after discharge. The primary end point was 90-day UTIs (defined as positive urine culture with >10⁵ cfu/mL associated with clinical symptoms, such as fever, chills, or flank pain). Secondary end points included adverse events, 90-day infectious complications, UTI-related readmissions, and cost. The final cohort included 40 in the SOC and 37 patients in the study arm, with follow-up ≥90 days. Median age was 69 years (IQR, 65-76), 19 (25%) were female, and 28 (36%) received neoadjuvant chemotherapy. Ten patients (25%) developed UTIs in the SOC vs 0% in the study arm (<i>P</i> = .001). There was no significant difference in complications or high-grade complications. Ninety-day infectious complications were 43% in the SOC arm vs 14% in the study arm (<i>P</i> = .006), and 90-day infection-related readmissions were 30% in the SOC vs 5% in the study arm (<i>P</i> = .007). The mean postcystectomy cost was $9074 lower in the treatment arm compared with the SOC (<i>P</i> = .007). The number needed to treat to prevent a single UTI was 4.0 (95% CI, 2.5-7.0). Prophylactic antibiotics for 30 days after RARC were associated with lower 90-day UTIs, infectious complications, UTI-related readmissions, and costs without an increase in adverse events.